What Researchers Did
Researchers reviewed systematic reviews and randomized controlled trials to update the appropriate role, indications, and evidence for hyperbaric oxygen therapy (HBOT) in wound care.
What They Found
They found that numerous small randomized controlled trials provide compelling support for HBOT, despite significant barriers to trial design due to the hyperbaric environment. Predictive models can identify patients most likely to benefit from HBOT, and electronic health records could facilitate their use, though clinical decision-making remains complicated.
What This Means for Canadian Patients
Canadian patients with advanced wounds might benefit from hyperbaric oxygen therapy, especially if predictive models can accurately identify those most likely to respond. This could lead to more targeted and effective treatment strategies for complex wound care.
Canadian Relevance
This review does not specifically mention any Canadian connection or data.
Study Limitations
The study acknowledges that the unique physics of the hyperbaric environment create significant barriers to designing robust clinical trials for HBOT.